The role of epigenetic pathways in defining pluripotent stem cell states in the embryo and ES cells
The role of epigenetic pathways in defining pluripotent stem cell states in the embryo and ES cells
批准号:
2665808
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2020
资助国家:
英国
项目状态:
未结题
起止时间:
2020 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Epigenetic modifications are found on the histones and DNA in the cell nucleus and are essential for embryo development. These epigenetic marks help to set up active and repressive chromatin states, which can propagate gene activity patterns in cell lineages but also regulate global nuclear architecture and chromosome function. The appearance of nuclear condensed chromatin in mouse embryogenesis coincides with differentiation and a restriction in developmental potential, but its causal involvement in these processes remains unclear. The derivation of embryonic stem (ES) cells from the embryo inner cell mass (ICM) results in their adoption of condensed chromatin, high levels of DNA methylation and repressive histone modifications that are not detectable in the ICM[1].Our project aims to gain understanding of the roles that epigenetic repression pathways play in the development of pluripotent cells in the mouse embryo and in cultured ES cells. In ES cells these pathways are dispensable but have been proposed to be involved in the conversion from 'serum state' to 'ground state', thought to more closely represent the pluripotent state in the embryo, as well as during differentiation to other cell fates.We hypothesise that epigenetic repression pathways may act in a three-dimensional and signalling context in the embryo, which may be less supported or disrupted when ES cells are cultured in a dish. We will explore this using a variety of experimental and advanced imaging approaches.The project aims to: (i) investigate the development of pluripotent ICM cells and other early cell fates in the preimplantation embryo, and the effects of inhibiting and downregulating epigenetic pathways on the formation of these cells. This will be compared with the effects of inhibition/down regulation of these pathways in cultured ES cells on cell markers and gene expression. (ii) develop a protocol using 'embryo-like' reconstitution methods that mix embryo placental trophectoderm stem cells with ES cells, allowing cells to self-organise into embryo-like structures[2]. Utilise this method for experiments mixing trophectoderm stem cells with existing mutant ES cell lines to record and determine whether mutant cells that act very similarly in a dish, display differences in behaviour in a 3-dimensional and signalling context in forming embryo-like assemblies.(iii) adapt live imaging reporter constructs for epigenetic modifications for use in ES cells and embryos.(iv) set up new imaging methodology to record multiple embryo-like assembly events occurring in a dish, based on 3D time lapse imaging by light sheet microscopy[3]. Embryo-like assemblies will be further analysed by fixation and immunostaining for stem cell and epigenetic markers.This PhD project involves three collaborating research groups, combining expertise in epigenetics in embryos and stem cells with expertise in advanced optical physics and engineering, to reveal context-dependent epigenetic signalling mechanisms and pathways acting in pluripotent cells. The research outcomes will provide more knowledge on the role of epigenetics in stem cells, which will lead to improved stem cell applications for bioscience and biomedicine. 1. Wongtawan, T., Taylor, J.E., Lawson, K.A., Wilmut, I., and Pennings, S. (2011). Histone H4K20me3 and HP1alpha are late heterochromatin markers in development, but present in undifferentiated embryonic stem cells. J Cell Sci 124, 1878-1890.2. Harrison, S.E., Sozen B., Christodoulou N., Kyprianou C., Zernicka-Goetz M. (2017). Assembly of embryonic and extraembryonic stem cells to mimic embryogenesis in vitro. Science. 356, (6334) doi: 10.1126/science.aal18103. Vettenburg T, Dalgarno HI, Nylk J, Coll-Llado C, Ferrier DE, Cizmar T, Gunn-Moore FJ, Dholakia K.Nat Methods. 2014 May;11(5):541-4. doi: 10.1038/nmeth.2922.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
NPM1表观重塑巨噬细胞代谢及修复表型在心肌缺血损伤中的调控作用
-
批准号:82371825
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:占贞贞
-
依托单位:
GLS1通过α-KG调控表观遗传修饰在实验性近视巩膜重塑中的作用机制
-
批准号:82371092
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:柯碧莲
-
依托单位:
小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究
-
批准号:32100593
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:童欣媛
-
依托单位:
MCM2、POLE3调控亲代组蛋白传递的分子机制和生物学功能
-
批准号:32070610
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:甘海云
-
依托单位:
转录因子剂量效应调控体细胞重编程的表观遗传机制研究
-
批准号:31970681
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:刘晶
-
依托单位:
组蛋白分子伴侣FACT调控异染色质转录沉默的作用机制研究
-
批准号:31900433
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:杨佳怡
-
依托单位:
探索VASH2转录激活对肝细胞癌血管生成和上皮间质转化的作用及机制
-
批准号:81172267
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:高文涛
-
依托单位:
肿瘤DNA低甲基化发生分子机理及其对白血病发病重要性的研究
-
批准号:30872933
-
项目类别:面上项目
-
资助金额:36.0万元
-
批准年份:2008
-
负责人:张权庚
-
依托单位:
高等植物远缘杂交诱导的表观遗传变异(epigenetic variation)现象及其在物种进化和新种形成中的作用
-
批准号:30430060
-
项目类别:重点项目
-
资助金额:140.0万元
-
批准年份:2004
-
负责人:刘宝
-
依托单位: